163 related articles for article (PubMed ID: 30284481)
1. Combining SERS analysis of serum with PSA levels for improving the detection of prostate cancer.
Stefancu A; Moisoiu V; Couti R; Andras I; Rahota R; Crisan D; Pavel IE; Socaciu C; Leopold N; Crisan N
Nanomedicine (Lond); 2018 Oct; 13(19):2455-2467. PubMed ID: 30284481
[TBL] [Abstract][Full Text] [Related]
2. Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL.
Chen N; Rong M; Shao X; Zhang H; Liu S; Dong B; Xue W; Wang T; Li T; Pan J
Int J Nanomedicine; 2017; 12():5399-5407. PubMed ID: 28794631
[TBL] [Abstract][Full Text] [Related]
3. Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
Zhou L; Liu Y; Wang F; Jia Z; Zhou J; Jiang T; Petti L; Chen Y; Xiong Q; Wang X
Talanta; 2018 Oct; 188():238-244. PubMed ID: 30029370
[TBL] [Abstract][Full Text] [Related]
4. Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer.
Qian H; Shao X; Zhu Y; Fan L; Zhang H; Dong B; Wang Y; Xu F; Zhen W; Kang X; Chen N; Liu S; Pan J; Xue W
Urol Oncol; 2020 Jun; 38(6):601.e1-601.e9. PubMed ID: 32241690
[TBL] [Abstract][Full Text] [Related]
5. Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S.
Pan J; Shao X; Zhu Y; Dong B; Wang Y; Kang X; Chen N; Chen Z; Liu S; Xue W
Int J Nanomedicine; 2019; 14():431-440. PubMed ID: 30666105
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer.
Cheng Z; Choi N; Wang R; Lee S; Moon KC; Yoon SY; Chen L; Choo J
ACS Nano; 2017 May; 11(5):4926-4933. PubMed ID: 28441008
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate cancer by Raman spectroscopy: A multivariate study on patients with normal and altered PSA values.
Correia NA; Batista LTA; Nascimento RJM; Cangussú MCT; Crugeira PJL; Soares LGP; Silveira L; Pinheiro ALB
J Photochem Photobiol B; 2020 Mar; 204():111801. PubMed ID: 31978674
[TBL] [Abstract][Full Text] [Related]
8. Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma.
Tan Y; Yan B; Xue L; Li Y; Luo X; Ji P
Lipids Health Dis; 2017 Apr; 16(1):73. PubMed ID: 28388900
[TBL] [Abstract][Full Text] [Related]
9. Surface-enhanced Raman spectroscopy of urine for prostate cancer detection: a preliminary study.
Del Mistro G; Cervo S; Mansutti E; Spizzo R; Colombatti A; Belmonte P; Zucconelli R; Steffan A; Sergo V; Bonifacio A
Anal Bioanal Chem; 2015 May; 407(12):3271-5. PubMed ID: 25791298
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of expressed prostatic secretion and serum using surface-enhanced Raman spectroscopy for the noninvasive detection of prostate cancer, a preliminary study.
Shao X; Pan J; Wang Y; Zhu Y; Xu F; Shangguan X; Dong B; Sha J; Chen N; Chen Z; Wang T; Liu S; Xue W
Nanomedicine; 2017 Apr; 13(3):1051-1059. PubMed ID: 27979746
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer detection based on serum sample surface enhanced Raman spectroscopy.
Vargas-Obieta E; Martínez-Espinosa JC; Martínez-Zerega BE; Jave-Suárez LF; Aguilar-Lemarroy A; González-Solís JL
Lasers Med Sci; 2016 Sep; 31(7):1317-24. PubMed ID: 27289243
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous immunoassays of dual prostate cancer markers using a SERS-based microdroplet channel.
Gao R; Cheng Z; Wang X; Yu L; Guo Z; Zhao G; Choo J
Biosens Bioelectron; 2018 Nov; 119():126-133. PubMed ID: 30121424
[TBL] [Abstract][Full Text] [Related]
13. SERS-based differential diagnosis between multiple solid malignancies: breast, colorectal, lung, ovarian and oral cancer.
Moisoiu V; Stefancu A; Gulei D; Boitor R; Magdo L; Raduly L; Pasca S; Kubelac P; Mehterov N; Chiș V; Simon M; Muresan M; Irimie AI; Baciut M; Stiufiuc R; Pavel IE; Achimas-Cadariu P; Ionescu C; Lazar V; Sarafian V; Notingher I; Leopold N; Berindan-Neagoe I
Int J Nanomedicine; 2019; 14():6165-6178. PubMed ID: 31447558
[TBL] [Abstract][Full Text] [Related]
14. Development of a high throughput (HT) Raman spectroscopy method for rapid screening of liquid blood plasma from prostate cancer patients.
Medipally DK; Maguire A; Bryant J; Armstrong J; Dunne M; Finn M; Lyng FM; Meade AD
Analyst; 2017 Apr; 142(8):1216-1226. PubMed ID: 28001146
[TBL] [Abstract][Full Text] [Related]
15. SERS-Based Pump-Free Microfluidic Chip for Highly Sensitive Immunoassay of Prostate-Specific Antigen Biomarkers.
Gao R; Lv Z; Mao Y; Yu L; Bi X; Xu S; Cui J; Wu Y
ACS Sens; 2019 Apr; 4(4):938-943. PubMed ID: 30864786
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Surface-Enhanced Raman Scattering Properties of Serum and Urine for the Detection of Chronic Kidney Disease in Patients.
Zong M; Zhou L; Guan Q; Lin D; Zhao J; Qi H; Harriman D; Fan L; Zeng H; Du C
Appl Spectrosc; 2021 Apr; 75(4):412-421. PubMed ID: 33031004
[TBL] [Abstract][Full Text] [Related]
17. A novel algorithm for the prediction of prostate cancer in clinically suspected patients.
Gallotta A; Ziglioli F; Ferretti S; Maestroni U; Moretti M; Aloe R; Gnocchi C; Di Palo M; Fassina G
Cancer Biomark; 2013; 13(4):227-34. PubMed ID: 24240583
[TBL] [Abstract][Full Text] [Related]
18. Knee osteoarthritis grading by resonant Raman and surface-enhanced Raman scattering (SERS) analysis of synovial fluid.
Bocsa CD; Moisoiu V; Stefancu A; Leopold LF; Leopold N; Fodor D
Nanomedicine; 2019 Aug; 20():102012. PubMed ID: 31085345
[TBL] [Abstract][Full Text] [Related]
19. Final Gleason score prediction using discriminant analysis and support vector machine based on preoperative multiparametric MR imaging of prostate cancer at 3T.
Citak-Er F; Vural M; Acar O; Esen T; Onay A; Ozturk-Isik E
Biomed Res Int; 2014; 2014():690787. PubMed ID: 25544944
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum prostate-specific antigen levels and the identification of prostate cancer in a large managed care population.
Wallner LP; Frencher SK; Hsu JW; Chao CR; Nichol MB; Loo RK; Jacobsen SJ
BJU Int; 2013 Jun; 111(8):1245-52. PubMed ID: 23320750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
